Internal Medicine, Nephrology · Montebello, CA
NPI
1912223850
Since 2010
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
3114 W Beverly Blvd
Montebello, CA, 90640
Phone (323) 726-3868
Groups this clinician bills Medicare through
Medicare paid, 2024
$259K
1,987 services
Medicare patients, 2024
550
Average age 71
Drug cost, 2024
$1.6M
3,320 prescriptions
Company payments, 2025
$1,974
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kay K Kyaw was code 99233 (hospital e&m - subsequent), 928 times for 303 patients. In total Kay K Kyaw billed 1,987 services in 18 codes, and Medicare paid $259K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 928 | 303 | $98.91 | $92K |
| 99223 Hospital E&M - Initial | Facility | 231 | 214 | $137.47 | $32K |
| 90960 ESRD Related Services (not dialysis) | Office | 181 | 101 | $282.52 | $51K |
| 99291 Critical Care E&M | Facility | 170 | 55 | $175.31 | $30K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 103 | 21 | $54.35 | $5,598 |
| 99215 Office E&M - Established | Office | 70 | 43 | $132.07 | $9,245 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 64 | 41 | $12.32 | $788 |
| 90961 ESRD Related Services (not dialysis) | Office | 62 | 48 | $231.59 | $14K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 48 | 21 | $42.09 | $2,020 |
| 99214 Office E&M - Established | Office | 16 | 16 | $41.56 | $665 |
By year: 2022 $243K for 1,642 services; 2023 $268K for 1,865 services; 2024 $259K for 1,987 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kay K Kyaw prescribed most often to Medicare patients was Furosemide, with 309 prescriptions and refills. In total Kay K Kyaw wrote 3,320 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Furosemide Generic | 309 | 449 | 67 | $1,087 |
| Lokelma Sodium Zirconium Cyclosilicate | 306 | 339 | 45 | $231K |
| Farxiga Dapagliflozin Propanediol | 274 | 280 | 49 | $154K |
| Velphoro Sucroferric Oxyhydroxide | 195 | 211 | 29 | $435K |
| Losartan Potassium Generic | 189 | 294 | 40 | $841 |
| Kerendia Finerenone | 162 | 163 | 18 | $98K |
| Epogen Epoetin Alfa | 156 | 156 | 29 | $94K |
| Dapagliflozin Dapagliflozin Propanediol | 107 | 107 | 21 | $52K |
| Atorvastatin Calcium Generic | 90 | 154 | 22 | $538 |
| Sevelamer Carbonate Generic | 88 | 105 | 17 | $14K |
| Lisinopril Generic | 69 | 132 | 20 | $374 |
| Nifedipine Er Nifedipine | 68 | 131 | 26 | $1,162 |
| Calcitriol Generic | 63 | 69 | 14 | $485 |
| Chlorthalidone Generic | 57 | 89 | 13 | $523 |
| Vitamin D2 Ergocalciferol (Vitamin D2) | 57 | 75 | 12 | $347 |
Brand drugs: 1,529 claims; generic drugs: 1,779 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kay K Kyaw $1,974 ($1,974 in general payments such as food, travel and fees) from 19 companies. The largest payer was Ardelyx, Inc. with $296.
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. ARDX | 13 | $296 |
| Amgen Inc. AMGN | 19 | $294 |
| Akebia Therapeutics Inc AKBA | 7 | $270 |
| GlaxoSmithKline, LLC. GSK | 11 | $205 |
| ANI Pharmaceuticals, Inc. ANIP | 9 | $155 |
| Travere Therapeutics, Inc. TVTX | 9 | $144 |
| Calliditas Therapeutics US Inc. | 4 | $119 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $77.26 |
| Fresenius USA Marketing, Inc. | 3 | $74.88 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $66.2 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.